154 related articles for article (PubMed ID: 37478669)
1. Long noncoding RNA DLEU1 promotes proliferation and glycolysis of gastric cancer cells via APOC1 upregulation by recruiting SMYD2 to induce trimethylation of H3K4 modification.
Xu H; Ba Z; Liu C; Yu X
Transl Oncol; 2023 Oct; 36():101731. PubMed ID: 37478669
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3.
Liu T; Han Z; Li H; Zhu Y; Sun Z; Zhu A
Mol Cancer; 2018 Aug; 17(1):118. PubMed ID: 30098595
[TBL] [Abstract][Full Text] [Related]
4. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
Zhang Y; Wu Y; Su X
Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
[No Abstract] [Full Text] [Related]
5. Neutrophil extracellular traps promote gastric cancer cell metastasis via the NAT10-mediated N4-acetylcytidine modification of SMYD2.
Liu D; Yang X; Wang X
Cell Signal; 2024 Apr; 116():111014. PubMed ID: 38110168
[TBL] [Abstract][Full Text] [Related]
6. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
Ding Y; Gao S; Zheng J; Chen X
Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLEU1 predicts poor prognosis of gastric cancer and contributes to cell proliferation by epigenetically suppressing KLF2.
Li X; Li Z; Liu Z; Xiao J; Yu S; Song Y
Cancer Gene Ther; 2018 May; 25(3-4):58-67. PubMed ID: 29282356
[TBL] [Abstract][Full Text] [Related]
8. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes.
Hatanaka Y; Niinuma T; Kitajima H; Nishiyama K; Maruyama R; Ishiguro K; Toyota M; Yamamoto E; Kai M; Yorozu A; Sekiguchi S; Ogi K; Dehari H; Idogawa M; Sasaki Y; Tokino T; Miyazaki A; Suzuki H
Sci Rep; 2021 Oct; 11(1):20438. PubMed ID: 34650128
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
Yue G; Chen C; Bai L; Wang G; Huang Y; Wang Y; Cui H; Xiao Y
Mol Med Rep; 2019 Nov; 20(5):4551-4557. PubMed ID: 31702026
[TBL] [Abstract][Full Text] [Related]
10. SMYD2 suppresses p53 activity to promote glucose metabolism in cervical cancer.
Wang Y; Jin G; Guo Y; Cao Y; Niu S; Fan X; Zhang J
Exp Cell Res; 2021 Jul; 404(2):112649. PubMed ID: 34015314
[TBL] [Abstract][Full Text] [Related]
11. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.
Guo T; Bai YH; Cheng XJ; Han HB; Du H; Hu Y; Jia SQ; Xing XF; Ji JF
Cancer Commun (Lond); 2021 Mar; 41(3):258-272. PubMed ID: 33570246
[TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme.
Wang J; Quan X; Peng D; Hu G
Mol Med Rep; 2019 Aug; 20(2):1873-1882. PubMed ID: 31257517
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer.
Pang B; Sui S; Wang Q; Wu J; Yin Y; Xu S
J Cell Physiol; 2019 Aug; 234(10):17420-17432. PubMed ID: 30793303
[TBL] [Abstract][Full Text] [Related]
14. Retracted Article: Long noncoding RNA DLEU1 promotes cell proliferation and migration of Wilms tumor through the miR-300/HOXC8 axis.
Ge W; Wang S
RSC Adv; 2019 Dec; 9(69):40240-40247. PubMed ID: 35542655
[TBL] [Abstract][Full Text] [Related]
15. Butyrate prevents the migration and invasion, and aerobic glycolysis in gastric cancer via inhibiting Wnt/β-catenin/c-Myc signaling.
Liang Y; Rao Z; Du D; Wang Y; Fang T
Drug Dev Res; 2023 May; 84(3):532-541. PubMed ID: 36782390
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lncRNA DLEU1 in Gastric Cancer Tissues Compared to Adjacent Non-Tumor Tissues.
Ghodrati R; Safaralizadeh R; Dastmalchi N; Hosseinpourfeizi M; Asadi M; Shirmohammadi M; Baradaran B
J Gastrointest Cancer; 2022 Dec; 53(4):990-994. PubMed ID: 34738190
[TBL] [Abstract][Full Text] [Related]
17. DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma.
Li Q; Zhang Z; Jiang H; Hou J; Chai Y; Nan H; Li F; Wang L
J Transl Med; 2022 May; 20(1):245. PubMed ID: 35619131
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA DLEU1 aggravates glioma progression via the miR-421/MEF2D axis.
Feng L; He M; Rao M; Diao J; Zhu Y
Onco Targets Ther; 2019; 12():5405-5414. PubMed ID: 31360066
[TBL] [Abstract][Full Text] [Related]
19. SMYD2 epigenetically activates MEX3A and suppresses CDX2 in colorectal cancer cells to augment cancer growth.
Pan L; Fan Y; Zhou L
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):959-969. PubMed ID: 35637161
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1.
Zhao J; Yang S; Lv C; Liu Y
Am J Physiol Cell Physiol; 2023 May; 324(5):C1039-C1052. PubMed ID: 36878845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
